Sunday, August 26, 2018 4:57:57 PM
2018-08-23 16:42 ET - News Release
Mr. Bob Rai reports
Vanc Pharmaceuticals Inc. has entered into a consulting agreement with Transcend Capital Inc. to develop and implement an investor relations program for the company. Transcend, with offices in Vancouver, B.C., is a full-service investor relations firm that assists small and mid-cap public companies with market awareness campaigns, and helps these companies gain valued industry exposure through an extensive network of retail and institutional clients. Etienne Moshevich is the sole owner of Transcend.
Transcend will provide comprehensive investor relations services to the company for an initial period of 24 months for an aggregate fee of $150,000 plus applicable taxes. Transcend and its directors, officers and employees are shareholders of the company, collectively holding approximately 3.5 per cent of the issued and outstanding common shares of the company.
The investor relations consulting agreement is subject to the approval of the TSX Venture Exchange.
About Vanc Pharmaceuticals Inc.
Vanc Pharmaceuticals aims to become the partner of choice for forward-thinking pharmacies across Canada. With an established sales force, distribution network, and team of highly experienced professionals in pharmacy, point-of-care testing and health technology, Vanc is growing beyond generics to provide pharmacists with innovative, value-added products and services to expand their scope of practice and support their evolving role as front-line healthcare providers.
We seek Safe Harbor.
© 2018 Canjex Publishing Ltd. All rights reserved.
https://www.stockwatch.com/News/Item.aspx?bid=Z-C%3aVANC-2650215&symbol=VANC®ion=C
all my posts are my opinion only. always do your own research.
Recent AVCRF News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/06/2024 08:07:30 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/09/2024 10:05:04 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/20/2024 10:05:41 AM
- Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] • Edgar (US Regulatory) • 06/12/2024 06:05:49 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/08/2024 10:08:07 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/06/2023 10:07:58 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM